GLYRX-PF
NDC 51754-6015, glycopyrrolate, injection, solution, from Exela Pharma Sciences, LLC.
- Product NDC
- 51754-6015
- Status
- Listed
- Labeler
- Exela Pharma Sciences, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210997
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51754-6015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE.2 mg/mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51754-6015-3 | 51754601503 | 10 SYRINGE, PLASTIC in 1 CARTON (51754-6015-3) / 5 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2189f3f5-39dc-4e85-b7c6-9515ded59686Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51754-6015
Use it
Look up 51754-6015 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51754-6015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51754-6015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.